Startseite A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
Artikel Open Access

A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques

  • Zijun Li EMAIL logo , Yaqin Zheng , Fangrong Shen , Ming Liu und Ying Zhou
Veröffentlicht/Copyright: 25. Oktober 2023

Abstract

Contemporary understanding of the dynamic anatomy of pelvic floor support has led us to new conservative surgery for uterine prolapse (UP). In this study, we comprehensively evaluate the safety and feasibility of a new technique for uterine-preserving pelvic organ prolapse surgery: laparoscopic rectus abdominis hysteropexy for uterine prolapse (LRAHUP). A retrospective study was conducted between 2006 and 2016. Sixty-five women diagnosed with advanced prolapsed uterus were eligible and grouped into traditional vaginal surgery (TVS, n = 30) group and new laparoscopic surgery (NLS, n = 35) group. Evaluated items of 65 cases included surgery-related parameters and postoperative outcomes. Surgical safety evaluating indicators, including operation time, blood loss, postoperative hospitalized day, and operation complications, also showed great significant difference between two groups (P < 0.05). The subjective index of post-operative Pelvic Floor Distress Inventory-short form 20 scores and some objective anatomic outcomes all showed great difference between pre- and post-operation (P < 0.05). Although the TVL showed no difference between pre- and post-operation in the same group, the TVL displayed a remarkable elongation. And a remarkable tendency was a higher cumulative recurrence ratio in the TVS group and a shorter follow-up period in the NLS group. LRAHUP may be a good procedure to manage women with advanced prolapsed uterus.

1 Introduction

Traditionally, vaginal total hysterectomy (VTH) is the basic surgical approach for uterine prolapse (UP) during the past few decades. However, vaginal hysterectomy alone often fails to address the underlying deficiencies in pelvic support that cause new vault prolapse. In fact, the incidence of vaginal fornix prolapse in women with UP after simple hysterectomy and vaginal repair is as high as 40% [1,2]. In other words, hysterectomy may be both the reason for and outcome of vaginal fornix prolapse, especially for women patients with pelvic organ prolapse (POP); in addition, the uterus and cervix may have an important role in sexual function and well-being [3]. Contemporary understanding of the dynamic anatomy of pelvic floor support has led us to new conservative surgery for POP, especially for the management of UP [3,4]. The uterus itself does not play a key role in the pathogenesis of UP [2]. Therefore, simple hysterectomy should not be the prime treatment and may increase the recurrence ratio of vault prolapse [2]. Many different mesh-based uterine-sparing operative techniques have been created to treat UP and restore the anatomy of pelvic organs during the past few years, such as laparoscopic sacrohysteropexy/sacrocolpopexy, bilateral sacrospinous hysteropexy, or posterior intravaginal slingplasty with conservation of the uterus, which was the commonly performed procedure [5,6]. However, many mesh-related complications reported by Food and Drug Administration showed only a small part of iceberg of far more serious mesh-related complications [7,8]. So far, more and more gynecologists focused on this key problem, which is how to treat UP women with acceptance of no mesh and uterus-sparing POP surgery [9,10,11].

Therefore, in this study, we conducted a small case series to investigate the safety and feasibility in women patients with advanced POP by comparing with traditional vaginal surgery (TVS), who underwent the uterine-preserving POP surgery named as laparoscopic rectus abdominis hysteropexy for uterine prolapse (LRAHUP).

2 Materials and methods

2.1 Study design

This single-center, retrospective observational study was approved by the Ethics Committee of Zhe-Jiang Quhua Hospital (approved on January 01, 2015; approval no.ECZJQH-201500038), and the procedure has been registered as a new intervention and was approved by the New Procedures Clinical Governance Committee of Zhe-Jiang Quhua Hospital in Zhejiang Province (NPCGCZJQH-201500038). Prior to the study of this new technology, I had already conducted clinical trials on five patients. Although this new technology is simple and easy to learn, considering the level of proficiency and the missing part of the collected data, the five subjects were not included in this study. All clinical data of enrolled 65 case patients were completely collected, including pre-operative general characteristics including age, parity, body mass index, pre-operative Pelvic Floor Distress Inventory-short form 20 (PFDI-20) scores [12], POP quantification (POP-Q) stages (Ⅰ–Ⅳ) [13] and Old Laceration of Perineum (OLP) degree (I–IV) [14], some surgery-related evaluating indexes including operation time, blood loss, post-operative hospitalized day, operation complications, incidence of stress urinary incontinence (SUI) after operation, pre- and post-operative POP-Q anatomic parameters, post-operative PFDI-20 scores, and cumulative recurrence within the periods of follow-up time. Recurrence was defined as objective POP-Q stage ≥ stage II at the anterior/posterior/apical vaginal wall [13,15].

2.2 Enrolled patients

The subjects were patients with advanced UP who were scheduled to undergo traditional VTH or the uterine-preserving UP surgery (LRAHUP) in the Department of Gynecology at Zhe-Jiang Qu-Hua Hospital from January 2006 to January 2016. All patients who met the enrolled criteria were described as follows: diagnosed with grade Ⅲ or IV UP according to the POP-Q proposed by Bump et al. [13], postmenopausal women without uncontrollable respiratory disorders and intractable constipation, without significant uterine enlargement (e.g., uterine fibroids), without previous POP surgery, without concomitant medical problems (e.g., endometrial and cervical lesions), and complete information of patients (e.g., follow-up). Moreover, for the convenience of research, women patients with severe degree of SUI were not enrolled in this study, and only 65 case patients with light, moderate, and occult SUI were enrolled [16]. All enrolled patients gave a written informed consent before acceptance of this new technique. Finally, 65 case postmenopausal patients were enrolled and studied.

2.3 Procedure

Sixty-five case patients were divided into two groups according to acceptance of different surgical methods: 30 patients underwent traditional vaginal hysterectomy and anterior/posterior vaginal wall repair, which were categorized as the TVS group, and 35 patients underwent a new uterine-preserving POP surgery named as LRAHUP, except for anterior and posterior vaginal wall repair, which were categorized as new laparoscopic surgery (NLS) group. These two surgical procedures were prepared in the same way before the operation, and the operations were carried out by the same chief physician in our hospital. The detailed surgical strategies for different POP in different groups are displayed in Table 1. Furthermore, the specific surgical procedures were also concomitantly inspected, assessed, and determined by a deputy chief physician and the chief physician who performed the operation. Before and after the operation, the pelvic floor situation of all patients was evaluated by POP-Q. And a subjective index was assessed by PFDI-20 [12], which included Pelvic Organ Prolapse Distress Inventory-6 (POPDI-6), Colorectal Anal Distress Inventory-8 (CRADI-8), and Urinary Distress Inventory-6 (UDI-6). Moreover, some objectively assessed indexes were also collected, including anatomic parameters before and 1 week after operation, and different follow-up time. All 65 patients were completely under a 5-year follow-up after surgery for pelvic floor repaired-related complications and improvements of symptoms. All clinical data, including the general pre-operative characteristics and many operation-related evaluating indexes of 65 patients, were obtained from the women’s clinical and follow-up records.

Table 1

Summary of different surgical strategies for 65 – case POP women

Variables TVS group NLS group
II III IV II III IV
AVWPYES-SUI ②+④ ②+④+⑥ ②+④+⑥ ②+④ ②+④+⑥ ②+④+⑥
AVWPNO-SUI ②+⑥ ②+⑥ ②+⑥ ②+⑥
UP ①+⑤ ①+⑤
PVWP
OLP

AVWPYES-SUI = anterior vaginal wall prolapse and with SUI, AVWPNO-SUI = anterior vaginal wall prolapse without SUI, UP = uterine prolapse, PVWP = posterior vaginal wall prolapse, ① = VTH, ② = anterior vaginal wall repair, ③ = posterior vaginal wall repair, ④ = Kelly’s operation, ⑤ = suspension of uterosacral ligament, ⑥ = repair of bladder fascia, ⑦ = LARHUP, ⑧ = repair of perineum.

2.4 Key steps of these new procedures of LRAHUP

The details of the procedures of new technique for uterine-preserving POP surgery (LRAHUP) are described below:

  1. First, to repair anterior and posterior vaginal wall repair as same as the TVS, repair of perineum and Kelly’s operation when necessary (e.g., light and moderate degree of SUI or occult SUI).

  2. Laparoscopic suture of bilateral proximal uterine horn and uterine body joint: to suture with big round needle No.10 non-absorbable silk string, as shown in Figure 1a–c.

  3. To make the adhesion surface of the anterior wall of uterine body burned and coagulated by monopole electro-coagulation (Figure 1d).

  4. One-cut and two-tunnel location: to pull or push the bottom of the uterine body to evaluate and locate the cut and puncture position between 2.0 and 3.0 cm above the pubic symphysis (PS) (Figure 1h).

  5. One-cut and two-tunnel puncture: first, one 15 mm diameter incision, second, a 5 mm diameter puncture instrument was first vertically punctured to the anterior sheath of rectus abdominis, and then it was punctured into the pelvic cavity on both sides with an inclined plane of 45° (Figure 1e and f).

  6. To pull the suture out of pelvic cavity, tighten up and knot: a laparoscopic forceps passed through two tunnels separately and pull out both ends of the suture to the outside of the pelvic cavity and tighten the knot (Figure 1g and h).

Figure 1 
                  Illustrated surgical key steps for LRAHUP.
Figure 1

Illustrated surgical key steps for LRAHUP.

2.5 Statistical analysis

Statistical analysis was carried out using SPSS 19.0 (SPSS Inc., Chicago, IL, USA). All measurement data, including pre-operative general characteristics, were analyzed using independent-samples t-test, and categorical counting data were analyzed using the chi-square or Pearson x 2 test and Fisher’s exact test. The constituent ratio was analyzed by Mann–Whitney U-test or Wilcoxon’s W test, and the comparisons of anatomic parameters were analyzed using analysis of variance (ANOVA). Moreover, construction and analysis of the interpolation line of relationship between the time of follow-up (lateral axis) and cumulative recurrence ratio (vertical axis) using graph tools of SPSS19.0; all P-values of <0.05 were considered statistically significant.

  1. Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

3 Results

3.1 General characteristics of 65 patients in different groups

The baseline characteristics of TVS and NLS groups were comparable, in terms of age, parity, body mass index, and PFDI-20 scores, including POPDI-6, CRADI-8, and UDI-6; there was no significant difference between two groups (all P-values >0.05) (Table 2).

Table 2

General characteristics of 65 case patients (M ± SD)

Variables TVS group NLS group *t/x 2 P
Age (years) 65.83 ± 5.73 64.71 ± 5.14 *0.830 0.410
Parity 2.87 ± 0.97 3.34 ± 1.33 7.678 0.175
Body Mass Index (kg/cm2) 20.13 ± 1.52 20.38 ± 1.60 *−0.641 0.524
PFDI-20 (pre-operation scores) 93.50 ± 20.96 92.28 ± 20.09 46.222 0.169
 POPDI-6 59.74 ± 7.20 57.01 ± 6.39 6.935 0.327
 CRADI-8 8.17 ± 9.36 11.82 ± 8.02 9.231 0.100
 UDI-6 25.57 ± 10.28 24.50 ± 12.87 12.317 0.550

* t = independent-samples T test, x 2 = x square test. M ± SD = mean ± standard deviation.

3.2 Constituent ratio of POP-Q stage and different surgical strategies for POP

The constituent ratio of PU, PPVW, PAVW, and OLP showed separately no great significant difference between two groups (all P-value >0.05) (Table 3).

Table 3

Constituent ratio of different degrees of POP-Q, OLP, and SUI

Variables TVS group NLS group Z P*
PU −0.520 0.603
 III (n = 57) 27(27/30) 30(30/35)
 IV (n = 8) 3(3/30) 5(5/35)
PPVW −0.433 0.665
 II (n = 29) 14(14/30) 15(15/35)
 III (n = 28) 13(13/30) 15(15/35)
 IV (n = 8) 3(3/30) 5(5/35)
PAVW −0.066 0.948
 II (n = 25) 12(12/30) 14(14/35)
 III (n = 32) 15(15/30) 17(17/35)
 IV (n = 7) 3(3/30) 4(4/35)
OLP −0.085 0.932
 II (n = 19) 10(10/30) 9(9/35)
 III (n = 3) 1(1/30) 2(2/35)
 IV (n = 0) 0 0
SUI −0.289 0.773
 Light degree 6(6/30) 8(8/35)
 Moderate degree 3(3/30) 5(5/35)
 Occult SUI 7(7/30) 6(6/35)

P*: Comparison between two group, P value obtained with Mann-Whitney U test or Wilcoxon W test.

3.3 Surgery-related evaluating indicators in different groups

The operation time, blood loss, post-operative hospitalized day, and operation complications all showed great significant difference between two groups (all P-values of <0.05) (Table 4). Although the patients of severe degree of SUI were not enrolled in this study, the incidence rate of SUI after operation showed a remarkable difference between two groups, with a rate of 26.67% (8/30) or 5.71%(2/35), respectively.

Table 4

Comparison of surgery-related evaluating indicators (M ± SD)

Variables TVS group NLS group *t/x 2 P
Operation time (minute) 121.23 ± 13.88 91.09 ± 11.47 *9.45 0.000
Blood loss (milliliter) 107.53 ± 29.46 63.20 ± 12.85 *7.64 0.000
Postoperative hospitalized day (day) 7.30 ± 1.68 4.63 ± 0.84 *7.88 0.000
Operation complications (%) 12 (12/30) 5 (5/35) 5.53 0.019
 Bladder injury 2 0
 Hematoma 4 2
 Urinary tract infection 4 1
 Voiding dysfunction 4 1
 Defecation dysfunction 3 2
SUI 8(8/30) 2(2/35) **5.448 0.035
 Light degree 2 1
 Moderate degree 1 1
 Occult SUI 5 0

*t: comparison by independent-samples t-test, x 2: Pearson’s x square test, **: Fisher’s exact test.

3.4 Scores of PFDI-20 between pre- and post-operation in different groups

The scores of post-operative overall PFDI-20 scores in 3 months and 6 months, respectively, showed great significance (all P-values = 0.000), and POPDI-6, CRADI-8, and UDI-6 all showed great difference between two groups (Table 5).

Table 5

Comparison of PFDI-20 of post-operation between different groups (M ± SD)

Follow-up time 3 months 6 months
Variables TVS group NLS group P* TVS group NLS group P*
PFDI-20 44.50 ± 13.29 30.35 ± 16.86 0.008 30.48 ± 9.18 14.16 ± 10.58 0.000
POPDI-6 24.98 ± 6.65 17.37 ± 8.03 0.000 17.70 ± 5.79 8.86 ± 7.16 0.000
CRADI-8 4.11 ± 5.13 3.29 ± 5.14 0.000 2.20 ± 2.88 1.57 ± 2.65 0.000
UDI-6 14.58 ± 3.84 9.69 ± 8.97 0.000 10.03 ± 4.44 3.44 ± 4.15 0.000

P*: Comparison between two groups, P value obtained with x square test.

3.5 Pre- and post-operative POP-Q anatomic parameters

All anatomic parameters, including Aa, Ba, C, Ap, Bp, TVL, Gh, and Bp, showed great difference between pre- and 1 week post-operation in the same group (all P values = 0.000). All anatomic parameters in pre-operation showed no significant difference between two groups (all P values of >0.05), and except for parameter Gh, all parameters in post-operation also showed great difference between two groups (all P values of <0.001). But the anatomic parameter D also showed great significant difference between pre- and post-operation only in the NLS group, because of non-existent parameter D after hysterectomy. Furthermore, the TVL of post-operation between two groups showed great significant difference (P = 0.000). And in the NLS group, the length of post-operative TVL displayed 1.0–2.0 cm elongation compared with that in the TVS group (P value = 0.000) (Table 6).

Table 6

Comparison of different anatomic parameters of POP-Q* between pre- and post-operation in different groups (M ± SD)

Variables TVS group (n = 30) NLS group (n = 35) P-value of different analysis
Pre- Post- Pre- Post P a P b P c P d
Aa (cm) 1.45 ± 1.04 −2.44 ± 0.44 1.63 ± 1.09 −2.84 ± 0.31 0.000 0.000 0.503 0.000
Ba (cm) 2.58 ± 0.94 −2.09 ± 0.58 2.37 ± 0.97 −2.7 ± 0.37 0.000 0.000 0.377 0.000
C (cm) 4.29 ± 1.18 6.37 ± 0.47 4.24 ± 1.48 −8.2 ± 0.96 0.000 0.000 0.896 0.000
TVL (cm) 7.08 ± 0.64 6.37 ± 0.47 7.21 ± 0.64 8.34 ± 0.85 0.000 0.000 0.417 0.000
Pb (cm) 3.00 ± 0.81 3.68 ± 0.53 3.11 ± 0.89 4.16 ± 0.34 0.000 0.000 0.593 0.000
Gh (cm) 4.33 ± 1.09 3.02 ± 0.38 4.20 ± 1.35 3.03 ± 0.21 0.000 0.000 0.667 0.874
Ap (cm) 1.47 ± 1.33 −2.49 ± 0.50 1.56 ± 1.22 −2.87 ± 0.28 0.000 0.000 0.775 0.000
Bp (cm) 2.33 ± 0.88 −2.03 ± 0.41 2.35 ± 1.05 −2.88 ± 0.26 0.000 0.000 0.910 0.000
D (cm) 3.17 ± 1.07 2.90 ± 0.94 −6.96 ± 0.70 0.000 0.275

*Pelvic organ prolapse quantification points, with measurements in cm relative to the position of the general hiatus.

Aa: a point located in the midline of the anterior vaginal wall, 3 cm proximal to the external urethral meatus.

Ba: the most distal/dependent point on the anterior vaginal wall from point Aa to the anterior vaginal fornix or vaginal cuff.

C: the most distal/dependent edge of the cervix or vaginal cuff (a measure of uterine descent).

D: the position of the posterior fornix.

Ap: a point located in the midline of the posterior vaginal wall, 3 cm proximal to the hymen.

Bp: the most distal/dependent point on the posterior vaginal wall above point Ap.

Pb: Perineal body. Gh: Genital hiatus. TVL: total vaginal length. cm = centimeter. –: no existed value.

aComparison between pre- and post-operation in the TVS group, P value obtained with paired sample T test.

bComparison between pre- and post-operation in the NLS group, P value obtained with paired sample T test.

cComparison between two groups before operation, P value obtained with ANOVA.

dComparison between two groups after operation, P value obtained with ANOVA.

3.6 Evaluation of the effect of LRAHUP by ultrasonography

Of 35 case patients who underwent LRAHUP, 91.43% (32/35) patients displayed good permanent adhesion between the anterior wall of the uterine body (yellow part) and the rectus abdominis (red part) at the end of 6-month follow-up after surgery (Figure 2a and b). And once this adhesion is formed, it is permanent and dense. This dense and permanent adhesion was also confirmed in laparoscopic surgery several years after cesarean section (Figure 2c).

Figure 2 
                  Ultrasound evaluation of postoperative effects of LRAHUP and clinical evidence of permanent adhesion.
Figure 2

Ultrasound evaluation of postoperative effects of LRAHUP and clinical evidence of permanent adhesion.

3.7 Cumulative case number of postoperative recurrence cases of POP

In the TVS group, the cumulative recurrence ratio of AC, PC, and AVS/MPC after operation all showed a remarkable tendency, which showed first an increase and finally reached to a platform between 48- and 60-month follow-up period. But in the NLS group, AVS/MPC showed a steady platform cumulative recurrence ratio within a shorter 6-month follow-up period (Figure 3). Finally, cumulative numbers of post-operative recurrence in different variables AC, PC, and AVS/MPC all showed great difference between two groups (all P-values of <0.001) (Table 7).

Figure 3 
                  Relationship between the time of follow-up (lateral axis) and cumulative recurrence ratio (vertical axis).
Figure 3

Relationship between the time of follow-up (lateral axis) and cumulative recurrence ratio (vertical axis).

Table 7

Cumulative recurrence ratio of different pelvic organ prolapsed in different follow-up time

Variables 6 months 12 months 18 months 36 months 48 months 60 months x 2 P*
AC 7.106 0.008
 TVS group 2/30 5/30 9/30 11/30 12/30 12/30
 NLS group 1/35 2/35 3/35 4/35 4/35 4/35
PC 9.142 0.002
 TVS group 0/30 2/30 4/30 7/30 9/30 9/30
 NLS group 0/35 1/35 1/35 1/35 1/35 1/35
AVS/MPC 8.186 0.004
 TVS group 1/30 4/30 7/30 9/30 10/30 10/30
 NLS group 2/35 2/35 2/35 2/35 2/35 2/35

AC = anterior compartment, PC = posterior compartment, AVS = apex of vaginal stump, MPC = median pelvic cavity. P*: comparison of cumulative recurrence ration between two groups, P value obtained with x 2 test.

4 Discussion

Although the female POP is a common problem in gynecology, the surgically treated women for POP constitute only 11% [17]. In the past few decades, trans-vaginal hysterectomy was the standard surgical treatment for UP; however, more and more gynecologists found that vaginal hysterectomy could not solve the problems of UP and maybe elevate the recurrence rate of apex of vaginal stump or vaginal vault prolapse [1,2]. Recently, several operations have been proposed for the treatment of prolapsed uterus [18,19], and currently, between 31 and 60% of women in the United States presenting for prolapsed care would elect to keep their uterus if surgical outcomes were equally efficacious [20]. An 11-year large population-based descriptive study in Taiwan showed a trend of uterine suspension with uterine preservation during the latter years [9], and the uterus preservation is always considered when there is no pathological finding of uterus [4,11]. Our small series demonstrated that the technique of LRAHUP described earlier is theoretically feasible and safe in this study. First, rectus abdominis is a strong hard tissue, which is very suitable for the suspension of prolapsed uterus. Second, there were no important vessels and nerves around the anterior sheath of rectus abdominis; therefore, the “one-cut and two-tunnel” puncture method described earlier was safety and feasible. Third, this new procedure is completely in line with a contemporary famous theory proposed by DeLancey [21], which combined with not only repair of anterior or posterior vaginal wall but also with repair of laceration of perineum and Kelly’s operation (Kelly’s plication) when necessary (e.g., OLP, SUI). Finally, the dense adhesion of the anterior wall of the uterine body could be evaluated by a method called “sliding sign” [22], so we can infer that it has clear and reliable evidence of the expected results after suspension and fixation of uterus, that is to say, this suspension and fixation of uterus is temporary and the result of adhesion between the anterior wall of uterine body and the rectus abdominis is permanent (e.g., as shown in Figure 2a–c). The aforementioned theoretical analysis is enough to illustrate that LRAHUP can be feasible in theory and clinical practice in the future. And this result had also been proven by Long et al. [23] in China.

In this study, LRAHUP, as a new strategy for UP, was introduced in detail by comparison with traditional vaginal hysterectomy. It had shown many advantages of peri-operative outcomes, which were, respectively, shorter operation time, less blood loss, no longer post-operative hospitalization day, and lower post-operative complications. Especially for surgery-related complications, LRAHUP showed a simple, rapid, and safety surgical procedure with uterus-sparing and without the little chance of bladder injury (0%). Although the pre-experimental sample size is small and may affect the reliability of the finally obtained experimental data, all of these data were consistent with recently reported findings [23]. Moreover, LRAHUP also demonstrated good subjective satisfaction confirmed by the comparison of PFDI-20 scores between different groups in pre- and post-operation within 3- or 6-month follow-up. But the Female Sexual Function Index (FSFI) questionnaire of 65 patients before and after surgery was not included in this study; it may be the main reason that the enrolled patients had few or no desire for sex (e.g., husband death, single), because of an elder mean age of 65.83 and 64.71 years, respectively, for different groups. In addition, educational level, weak sexual awareness, and traditional sexual beliefs may also be some of the reasons not included in this study. It is recommended to include it in subsequent studies. Most interesting result is the lower incidence rate of SUI after operation in the NLS group, compared with that in the TVS group, although the same Kelly’s placation for SUI was performed on patients. This good result of lower incidence rate of SUI may be caused by the new technique of LRAHUP, which may help in indirect correction of SUI by the rectification of the mid-pelvic defects; while indirectly reinforcing the anterior pelvic cavity, the recurrence rate of SUI is indirectly reduced [24]. However, the exact reason for the lower incidence of SUI in the NLS group needs further study in terms of urodynamics.

The objective anatomic parameters also confirmed higher effective outcomes of an anatomical cure, including Aa, Ba, C, Ap and Bp, by comparison between pre- and post-operation in the same group, or between two groups in post-operation. And in the NLS group, the anatomic parameters all showed better advantages compared with those in the TVS group. Furthermore, concerning the anatomic parameter of TVL, the former showed a 1.0–2.0 cm elongation of TVL compared with that in the TVS group and this result was also confirmed by a recent study [23]. However, this good result of elongation of TVL improved the satisfaction of sex; unfortunately, this study did not involve. However, many scholars [25,26] had found that the impact of different methods of hysterectomy on vaginal length is in the following order: transvaginal > transabdominal > laparoscopic > robotic, while there was no significant difference in the impact on sexual activity between the two groups. In addition, post-operative dyspareunia is more common after vaginal hysterectomy compared to that after abdominal hysterectomy, This may be attributed to post-operative shortening of the vagina secondary to excessive trimming of the vaginal walls especially if VH was performed for utero-vaginal prolapse [27,28]. In summary, further research is needed to confirm the impact of extending vaginal length on patients’ sexual satisfaction, especially for young women.

Theoretically, uterine ventral suspension causes an upward traction of anterior vaginal wall, helping to correct the anterior compartment prolapse as well. However, there were many research reports that this suspension only created an anatomical cure rate of 85% in the anterior compartment [10], slightly lower than a recent study showing 91% following laparoscopic sacral hysteropexy [29]. This may be due to the fact that sole suspension of prolapsed uterus could not completely solve the problem of anterior compartment prolapse. Especially for those patients with anterior vaginal wall prolapse stage III (Ba > +1) pre-operatively, they showed a higher rate of recurrence [23]. A review study concluded that laparoscopic uterine ventro-suspension using round ligaments has a very limited role, with a success rate less than 50% [10]. It is apparent that elongation of round ligament by uterine weight causes a higher recurrence of UP. However, in this study, we performed on 65 patients with anterior vaginal wall prolapse stage II–IV not only uterus-sparing surgery of LRAHUP or vaginal hysterectomy but also anterior/posterior vaginal wall repair. Finally, results displayed that the different cumulative recurrence rates of AC/PC/MPC prolapse in the NLS group were at all remarkable lower levels compared with the TVS group after post-operation 5-year follow-up. Especially for the recurrence rate of AC/PC, 65 case patients who underwent the same procedure for AC/PC prolapse showed different results of clinical outcome. The above-described conclusions did not seem to accord with the clinical practice, because of which were the same procedure for anterior/posterior vaginal wall repair performed on 65 patients, and the sole different key point was the different procedure for prolapsed uterus between two groups. In other words, different procedures for UP with or without uterus-preserving POP surgery completely elaborated the reason for this above-described accordance with the clinical practice. It is well known that the correction of prolapsed MPC/AVS is a key and crucial problem; a good effective procedure for UP can help not only reduce the recurrence ratio of MPC but also lower the recurrence rate of AC/PC prolapse [30,31]. This evidence also reinforces the importance of safe and effective apical support and the clinical value of McCall or modified McCall procedures in preventing the occurrence of POP after hysterectomy because the principle of the McCall culdoplasty is to elevate the vaginal vault and obliterate the posterior cul-de-sac [29]. However, the preventive effect of McCall or modified McCall procedures on recurrence after hysterectomy in patients with POP remains to be further studied [32,33]. In this study, two strategies, namely, LRAHUP and traditional TVL for advanced UP, were all implemented. In addition, TVL procedure is relatively complex and difficult to perform in grassroots hospitals, and LRAHUP procedure is simple and easy to perform. Finally, the most important findings in this study showed that a longer follow-up period of 48–60 months in the TVS group according to the follow-up time taken to reach the platform, but only 6–12-month follow-up in the NLS group. This can guide and shorten the post-operative follow-up of time for LRAHUP.

In summary, the new technique of LRAHUP for uterus-sparing POP surgery, described and studied in detail, was confirmed a safety, simple, and effective procedure for those patients diagnosed with advanced UP, because of its safety, simplicity, feasibility, lower post-operative complications, better subjective assessment of PFDI-20 scores, better anatomic outcomes, elongation of TVL, lower cumulative recurrence ratio, and shorter follow-up period after operation. Although this study showed many good results, a little of flaw was displayed, including the absence of young pre-menopausal women patients and the FSFI questionnaire in this study. In particular, the overall improvement of quality of life and sexual function requires multidisciplinary management of POP, which has also attracted the attention of many clinical urologists and gynecologists [34]. So the disadvantages of the procedure of LRAHUP for uterus-preserving POP surgery still needed to be further studied with large sample and multicenters.

5 Conclusions

The LRAHUP may be a good procedure, because of its safety, simplicity, better anatomic outcome, better subjective assessment of PFDI-20 scores, elongation of TVL, lower cumulative recurrence ratio, and shorter follow-up period.

  1. Funding information: No funding was provided for this study.

  2. Conflict of interest: All authors declare no support from any organization for the submitted work; no financial relationships with any organizations and no other relationships or activities could appear to have influenced the submitted work.

  3. Data availability statement: The datasets generated during and/or analyzed during this study are available from the corresponding author on a reasonable request.

References

[1] Lykke R, Blaakaer J, Ottesen B, Gimbel H. The indication for hysterectomy as a risk factor for subsequent pelvic organ prolapsed repair. Int Urogynecol J. 2015;26:1661–5. 10.1007/s00192-015-2757-y.Suche in Google Scholar PubMed

[2] Marchionni M, Bracco GL, Checcucci V, Carabaneanu A, Coccia EM, Mecacci F, et al. True incidence of vaginal vault prolapse: thirteen years of experience. J Reprod Med. 1999;44:679–84. 10.1023/A:1020554216254.Suche in Google Scholar PubMed PubMed Central

[3] Meriwether KV, Antosh DD, Olivera CK, Shunaha KF, Balk EM, Murphy M, et al. Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines. Am J Obstet Gynecol. 2018;219:129–46.e2. 10.1016/j.ajog.2018.01.018.Suche in Google Scholar PubMed

[4] Anglim B, O’Sullivan O, O’Reilly B. How do patients and surgeons decide on uterine preservation or hysterectomy in apical prolapse? Int Urogynecol J. 2018;29:1075–9. 10.1007/s00192-018-3685-4.Suche in Google Scholar PubMed

[5] American Urogynecologic Society’s Guidelines Development, Committee. Guidelines for privileging and credentialing physicians for sacrocolpopexy for pelvic organ prolapse. Female Pelvic Med Recontruct Surg. 2013;19:62–5. 10.1097/SPV.0b013e318289c018.Suche in Google Scholar PubMed

[6] Schulten SFM, Detollenaere RJ, Stekelenburg J, IntHout J, Kluivers KB, van Eijndhoven HWF. Sacrospinous hysteropexy versus vaginal hysterectomy with uterosacral ligament suspension in women with uterine prolapse stage 2 or higher: observational follow-up of a multicentre randomized trial. BMJ. 2019;366:l5149. 10.1136/bmj.l5149.Suche in Google Scholar PubMed PubMed Central

[7] Gutman RE, Rardin CR, Sokol ER, Matthews C, Park AJ, BIglesia C, et al. Vaginal and laparoscopic mesh hysteropexy for uterovaginal prolapse: a parallel cohort study. Am J Obstet Gynecol. 2017;216(1):38.e1–11. 10.1016/j.ajog.2016.08.035.Suche in Google Scholar PubMed

[8] Skoczylas LC, Turner LC, Wang L, Winger DG, Shepherd JP. Changes in prolapse surgery trends relative to FDA notifications regarding vaginal mesh. Int Urogynecol J. 2014;25(4):471–7. 10.1007/s00192-013-2231-7.Suche in Google Scholar PubMed PubMed Central

[9] Wu MP, Long CY, Huang KH, Chu CC, Liang CC, Tang CH. Changing trends of surgical approaches for uterine prolapse: An 11-year population based nationwide descriptive study. Int Urogynecol J. 2012;7:865–72. 10.1007/s00192-011-1647-1.Suche in Google Scholar PubMed

[10] Lin LL, Ho MH, Haessler AL, Betson LH, Alinsod RM, Liu CY, et al. A review of laparoscopic uterine suspension procedures for uterine preservation. Curr Opin Obstet Gynecol. 2015;17:541–6. 10.1097/01.gco.0000179664.83154.9c.Suche in Google Scholar PubMed

[11] Korbly NB, Kassis NC, Good MM, Richardson ML, Book NM, Yip S, et al. Patient preferences for uterine preservation and hysterectomy in women with pelvic organ prolapse. Am J Obstet Gynecol. 2013;209:470.e1–6. 10.1016/j.ajog.2013.08.003.Suche in Google Scholar PubMed

[12] Barber MD, Chen Z, Lukacz E, Markland A, Wai C, Brubaker L, et al. Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). Neurourol Urodyn. 2011;30:541–6. 10.1002/nau.20934.Suche in Google Scholar PubMed PubMed Central

[13] Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175:10–7. 10.1016/s0002-9378(96)70243-0.Suche in Google Scholar PubMed

[14] Sultan AH, Monga AK, Kumar D, Stanton SL. Primary repair of obstetric anal sphincter rupture using the overlap technique. Br J Obstet Gynaecol. 1999;106(4):318–23. 10.1111/j.1471-0528.1999.tb08268.x.Suche in Google Scholar PubMed

[15] Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, et al. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27:655–84. 10.1007/s00192-015-2932-1.Suche in Google Scholar PubMed

[16] Deutchman M, Wulster-Radcliffe M. Stress urinary incontinence in women: diagnosis and medical management. Med Gen Med. 2005;7(4):62, PMID: 16614684; PMCID: PMC1681740.Suche in Google Scholar

[17] Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–6. 10.1016/S0029-7844(97)00058-6.Suche in Google Scholar PubMed

[18] Baessler K, Christmann-Schmid C, Maher C, Haya N, Crawford TJ, Brown J, et al. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence. Cochrane Database Syst. 2018;8:CD013108. 10.1002/14651858.CD013108CD013108.Suche in Google Scholar

[19] van IJsselmuiden MN, Detollenaere RJ, Kampen MY, Engberts MK, van Eijndhoven HW. Practice pattern variation in surgical management of pelvic organ prolapse and urinary incontinence in The Netherlands. Int Urogynecol J. 2015;26:1649–56. 10.1007/s00192-015-2755-0.Suche in Google Scholar PubMed

[20] Gutman RE. Does the uterus need to be removed to correct uterovaginal prolapsed. Curr Opin Obstet Gynecol. 2016;28(5):435–40. 10.1097/GCO.0000000000000307.Suche in Google Scholar PubMed

[21] Delancy JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol. 1992;166(6 Pt 1):1717–24. 10.1016/0002-9378(92)91562-o.Suche in Google Scholar PubMed

[22] Baron J, Tirosh D, Mastrolia SA, Ben-Haroush Y, Schwartz S, Kerner Y, et al. Sliding sign in third-trimester sonographic evaluation of intra-abdominal adhesions in women undergoing repeat Cesarean section: a novel technique. Ultrasound Obstet Gynecol. 2018;52(5):662–5. 10.1002/uog.19057.Suche in Google Scholar PubMed

[23] Long CY, Wang CL, Ker CR, Juan YS, Tsai EM, Lin KL. Laparoscopic organopexy with non mesh genital (LONG) suspension: a novel uterine preservation procedure for the treatment of apical prolapse. Sci Rep. 2018;8:4872. 10.1038/s41598-018-23285-7.Suche in Google Scholar PubMed PubMed Central

[24] American Urogynecologic Society and American College of Obstetricians and Gynecologists. Committee opinion: evaluation of uncomplicated stress urinary incontinence in women before surgical treatment. Female Pelvic Med Reconstr Surg. 2014;20(5):248–51. 10.1097/SPV.0000000000000113.Suche in Google Scholar PubMed

[25] Koroglu N, Aslan Cetin B, Akca A, Turan G, Temel Yuksel I, Safak Yıldırım I, et al. A comparison of pelvic organ prolapse and sexual function after abdominal and laparoscopic hysterectomy. Ginekol Pol. 2018;89(10):553–7. 10.5603/GP.a2018.0094.Suche in Google Scholar PubMed

[26] De La Cruz JF, Myers EM, Geller EJ. Vaginal versus robotic hysterectomy and concomitant pelvic support surgery: a comparison of postoperative vaginal length and sexual function. J Minim Invasive Gynecol. 2014 Nov–Dec;21(6):1010–4. 10.1016/j.jmig.2014.04.011.Suche in Google Scholar PubMed

[27] Abdelmonem AM. Vaginal length and incidence of dyspareunia after total abdominal versus vaginal hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2010 Aug;151(2):190–2. 10.1016/j.ejogrb.2010.03.031. Epub 2010 Apr 27 PMID: 20427116.Suche in Google Scholar PubMed

[28] Tunuguntla HS, Gousse AE. Female sexual dysfunction following vaginal surgery: a review. J Urol. 2006 Feb;175(2):439–46. 10.1016/S0022-5347(05)00168-0.Suche in Google Scholar PubMed

[29] Krause HG, Goh JT, Sloane K, Higgs P, Carey MP. Laparoscopic sacral suture hysteropexy for uterine prolapsed. Int Urogynecol J. 2006;17:378–81. 10.1007/s00192-005-0019-0.Suche in Google Scholar PubMed

[30] Rooney K, Kenton K, Mueller ER, FitzGerald MP, Brubaker L. Advanced anterior vaginal wall prolapse is highly correlated with apical prolapse. Am J Obstet Gynecol. 2006;195(6):1837–40. 10.1016/j.ajog.2006.06.065.Suche in Google Scholar PubMed

[31] Kong MK, Bai SW. Surgical treatments for vaginal prolapse. Obstet Gynecol Sci. 2016;59(4):253–60. 10.5468/ogs.2016.59.4.253.Suche in Google Scholar PubMed PubMed Central

[32] Niblock K, Bailie E, McCracken G, Johnston K. Vaginal McCall culdoplasty versus laparoscopic uterosacral plication to prophylactically address vaginal vault prolapse. Gynecol Surg. 2017;14(1):3. 10.1186/s10397-017-1006-4.Suche in Google Scholar PubMed PubMed Central

[33] Carlin GL, Bodner-Adler B, Husslein H, Ritter M, Umek W. The effectiveness of surgical procedures to prevent post-hysterectomy pelvic organ prolapse: a systematic review of the literature. Int Urogynecol J. 2021;32(4):775–83. 10.1007/s00192-020-04572-2.Suche in Google Scholar PubMed PubMed Central

[34] La Rosa VL, Ciebiera M, Lin LT, Sleiman Z, Cerentini TM, Lordelo P, et al. Multidisciplinary management of women with pelvic organ prolapse, urinary incontinence and lower urinary tract symptoms. A clinical and psychological overview. Prz Menopauzalny. 2019;18(3):184–90. 10.5114/pm.2019.89496.Suche in Google Scholar PubMed PubMed Central

Received: 2022-12-10
Revised: 2023-08-20
Accepted: 2023-10-08
Published Online: 2023-10-25

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Research Articles
  2. Exosomes derived from mesenchymal stem cells overexpressing miR-210 inhibits neuronal inflammation and contribute to neurite outgrowth through modulating microglia polarization
  3. Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia
  4. circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway
  5. circRNA ITGA7 restrains growth and enhances radiosensitivity by up-regulating SMAD4 in colorectal carcinoma
  6. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
  7. Up-regulation of collagen type V alpha 2 (COL5A2) promotes malignant phenotypes in gastric cancer cell via inducing epithelial–mesenchymal transition (EMT)
  8. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis
  9. 3D-printed polyether-ether-ketone/n-TiO2 composite enhances the cytocompatibility and osteogenic differentiation of MC3T3-E1 cells by downregulating miR-154-5p
  10. Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer
  11. PVT1/miR-16/CCND1 axis regulates gastric cancer progression
  12. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
  13. Short-term outcomes after simultaneous gastrectomy plus cholecystectomy in gastric cancer: A pooling up analysis
  14. SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
  15. Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung
  16. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis
  17. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis
  18. Glycoprotein non-metastatic melanoma B interacts with epidermal growth factor receptor to regulate neural stem cell survival and differentiation
  19. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
  20. Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide β glypeptide: A cross-sectional study in elder Chinese population
  21. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
  22. Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
  23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
  24. Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial
  25. Lycopene ameliorates locomotor activity and urinary frequency induced by pelvic venous congestion in rats
  26. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats
  27. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
  28. Ultra-high-performance liquid chromatography-tandem mass spectrometry analysis of serum metabolomic characteristics in people with different vitamin D levels
  29. Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
  30. circ_0014736 induces GPR4 to regulate the biological behaviors of human placental trophoblast cells through miR-942-5p in preeclampsia
  31. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
  32. Effects of osteogenic growth peptide C-terminal pentapeptide and its analogue on bone remodeling in an osteoporosis rat model
  33. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
  34. WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients
  35. Radiomics model using preoperative computed tomography angiography images to differentiate new from old emboli of acute lower limb arterial embolism
  36. Dysregulated lncRNAs are involved in the progress of myocardial infarction by constructing regulatory networks
  37. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy
  38. Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk
  39. Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
  40. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
  41. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
  42. CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p
  43. Exosomal miR-93-5p regulated the progression of osteoarthritis by targeting ADAMTS9
  44. Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
  45. HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
  46. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study
  47. Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
  48. A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis
  49. Impact of omicron wave and associated control measures in Shanghai on health management and psychosocial well-being of patients with chronic conditions
  50. Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer
  51. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
  52. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
  53. miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy
  54. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
  55. IRF6 and FGF1 polymorphisms in non-syndromic cleft lip with or without cleft palate in the Polish population
  56. Comprehensive analysis of the role of SFXN family in breast cancer
  57. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
  58. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression
  59. AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway
  60. Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
  61. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
  62. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
  63. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
  64. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
  65. Ultrasound examination supporting CT or MRI in the evaluation of cervical lymphadenopathy in patients with irradiation-treated head and neck cancer
  66. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway
  67. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis
  68. Long noncoding RNA Mhrt alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway
  69. Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
  70. Cholesterol induces inflammation and reduces glucose utilization
  71. circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
  72. NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway
  73. The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
  74. miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
  75. Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis
  76. α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
  77. Changes of microbiota level in urinary tract infections: A meta-analysis
  78. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
  79. Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
  80. Outcomes of low-risk birth care during the Covid-19 pandemic: A cohort study from a tertiary care center in Lithuania
  81. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway
  82. Integrated transcriptome analysis identifies APPL1/RPS6KB2/GALK1 as immune-related metastasis factors in breast cancer
  83. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
  84. Circular RNA Circ_0038467 promotes the maturation of miRNA-203 to increase lipopolysaccharide-induced apoptosis of chondrocytes
  85. An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
  86. Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
  87. Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
  88. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma
  89. miR-141-3p accelerates ovarian cancer progression and promotes M2-like macrophage polarization by targeting the Keap1-Nrf2 pathway
  90. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
  91. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
  92. Subjective well-being in informal caregivers during the COVID-19 pandemic
  93. Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission
  94. Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
  95. Bladder cancer screening: The new selection and prediction model
  96. circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
  97. Prone position effect in intensive care patients with SARS-COV-2 pneumonia
  98. Clinical observation on the efficacy of Tongdu Tuina manipulation in the treatment of primary enuresis in children
  99. Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway
  100. Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
  101. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
  102. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  103. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
  104. Clinical significance of serum MBD3 detection in girls with central precocious puberty
  105. Clinical features of varicella-zoster virus caused neurological diseases detected by metagenomic next-generation sequencing
  106. Collagen treatment of complex anorectal fistula: 3 years follow-up
  107. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
  108. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
  109. SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
  110. A prospective cohort study of the impact of chronic disease on fall injuries in middle-aged and older adults
  111. circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis
  112. hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
  113. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis
  114. lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation
  115. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
  116. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
  117. Anti-inflammatory effect of ApoE23 on Salmonella typhimurium-induced sepsis in mice
  118. Analysis of somatic mutations and key driving factors of cervical cancer progression
  119. Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
  120. Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases
  121. Effects of pharmacological delay with roxadustat on multi-territory perforator flap survival in rats
  122. Analysis of heroin effects on calcium channels in rat cardiomyocytes based on transcriptomics and metabolomics
  123. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study
  124. Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
  125. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
  126. Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
  127. The protective effect of caffeic acid phenethyl ester in the nephrotoxicity induced by α-cypermethrin
  128. Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
  129. Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
  130. The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity
  131. Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
  132. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
  133. Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
  134. The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
  135. Circ-UBR4 regulates the proliferation, migration, inflammation, and apoptosis in ox-LDL-induced vascular smooth muscle cells via miR-515-5p/IGF2 axis
  136. Clinical characteristics of current COVID-19 rehabilitation outpatients in China
  137. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
  138. miR-199a-5p inhibits aortic valve calcification by targeting ATF6 and GRP78 in valve interstitial cells
  139. The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial
  140. Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
  141. The effects of progesterone on the healing of obstetric anal sphincter damage in female rats
  142. Identification of cuproptosis-related genes for predicting the development of prostate cancer
  143. Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity
  144. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
  145. A single center prospective study: Influences of different hip flexion angles on the measurement of lumbar spine bone mineral density by dual energy X-ray absorptiometry
  146. Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis
  147. Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis
  148. Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
  149. A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors
  150. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
  151. Pepsin concentration in oral lavage fluid of rabbit reflux model constructed by dilating the lower esophageal sphincter
  152. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
  153. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress
  154. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy
  155. Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
  156. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis
  157. LncRNA LINC00592 mediates the promoter methylation of WIF1 to promote the development of bladder cancer
  158. Factors associated with gastrointestinal dysmotility in critically ill patients
  159. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways
  160. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
  161. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1
  162. Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 2022
  163. Ferroptosis involves in Schwann cell death in diabetic peripheral neuropathy
  164. The effect of AQP4 on tau protein aggregation in neurodegeneration and persistent neuroinflammation after cerebral microinfarcts
  165. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
  166. Analysis of clinical characteristics in proximal and distal reflux monitoring among patients with gastroesophageal reflux disease
  167. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients
  168. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
  169. Bibliometrics and knowledge map analysis of ultrasound-guided regional anesthesia
  170. Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
  171. D-dimer trends predict COVID-19 patient’s prognosis: A retrospective chart review study
  172. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
  173. Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
  174. Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
  175. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
  176. Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease
  177. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
  178. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
  179. A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
  180. Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
  181. A comparative study on the overlapping effects of clinically applicable therapeutic interventions in patients with central nervous system damage
  182. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up
  183. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: An up-to-date meta-analysis of 4,073 patients
  184. Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
  185. CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
  186. Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
  187. KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11
  188. Evaluation of placental oxygenation by near-infrared spectroscopy in relation to ultrasound maturation grade in physiological term pregnancies
  189. The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
  190. Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
  191. Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
  192. Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients
  193. Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation
  194. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway
  195. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
  196. lncRNA LENGA sponges miR-378 to promote myocardial fibrosis in atrial fibrillation
  197. Diagnostic value of urinary Tamm-Horsfall protein and 24 h urine osmolality for recurrent calcium oxalate stones of the upper urinary tract: Cross-sectional study
  198. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
  199. The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
  200. Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
  201. MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway
  202. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
  203. Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells
  204. Predictors of gastrointestinal complaints in patients on metformin therapy
  205. Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
  206. A retrospective analysis of the effect of latent tuberculosis infection on clinical pregnancy outcomes of in vitro fertilization–fresh embryo transferred in infertile women
  207. Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience
  208. miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
  209. Clinical features and management of lymphoepithelial cyst
  210. Serum VEGF, high-sensitivity CRP, and cystatin-C assist in the diagnosis of type 2 diabetic retinopathy complicated with hyperuricemia
  211. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi
  212. Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
  213. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study
  214. Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units
  215. Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction
  216. Long-term administration of probiotics prevents gastrointestinal mucosal barrier dysfunction in septic mice partly by upregulating the 5-HT degradation pathway
  217. miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
  218. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
  219. Review Articles
  220. Prenatal diagnosis of fetal defects and its implications on the delivery mode
  221. Electromagnetic fields exposure on fetal and childhood abnormalities: Systematic review and meta-analysis
  222. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae
  223. Saddle pulmonary embolism in the setting of COVID-19 infection: A systematic review of case reports and case series
  224. Vitamin C and epigenetics: A short physiological overview
  225. Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
  226. Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
  227. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
  228. Surgical management and outcomes of traumatic global brachial plexus injury: A concise review and our center approach
  229. The progress of autoimmune hepatitis research and future challenges
  230. METTL16 in human diseases: What should we do next?
  231. New insights into the prevention of ureteral stents encrustation
  232. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
  233. Case Reports
  234. Mycobacterium xenopi infection of the kidney and lymph nodes: A case report
  235. Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report
  236. Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report
  237. Liver abscess complicated with multiple organ invasive infection caused by hematogenous disseminated hypervirulent Klebsiella pneumoniae: A case report
  238. Urokinase-based lock solutions for catheter salvage: A case of an upcoming kidney transplant recipient
  239. Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation
  240. Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
  241. Does total hip arthroplasty result in intercostal nerve injury? A case report and literature review
  242. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review
  243. Synchronous triple primary gastrointestinal malignant tumors treated with laparoscopic surgery: A case report
  244. CT-guided percutaneous microwave ablation combined with bone cement injection for the treatment of transverse metastases: A case report
  245. Malignant hyperthermia: Report on a successful rescue of a case with the highest temperature of 44.2°C
  246. Anesthetic management of fetal pulmonary valvuloplasty: A case report
  247. Rapid Communication
  248. Impact of COVID-19 lockdown on glycemic levels during pregnancy: A retrospective analysis
  249. Erratum
  250. Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
  251. Erratum to: “Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p”
  252. Retraction
  253. Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
  254. Retraction of “circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis”
  255. Retraction of “miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells”
  256. Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”
  257. Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
  258. Retraction of “lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells”
  259. Special issue Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases
  260. Effect of cardiac rehabilitation therapy on depressed patients with cardiac insufficiency after cardiac surgery
  261. Special issue The evolving saga of RNAs from bench to bedside - Part I
  262. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
  263. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part III
  264. Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
Heruntergeladen am 1.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/med-2023-0833/html
Button zum nach oben scrollen